198 related articles for article (PubMed ID: 17885061)
1. Radiofrequency ablation in the management of liver metastases from breast cancer.
Sofocleous CT; Nascimento RG; Gonen M; Theodoulou M; Covey AM; Brody LA; Solomon SM; Thornton R; Fong Y; Getrajdman GI; Brown KT
AJR Am J Roentgenol; 2007 Oct; 189(4):883-9. PubMed ID: 17885061
[TBL] [Abstract][Full Text] [Related]
2. Resection of liver metastases in patients with breast cancer: survival and prognostic factors.
van Walsum GA; de Ridder JA; Verhoef C; Bosscha K; van Gulik TM; Hesselink EJ; Ruers TJ; van den Tol MP; Nagtegaal ID; Brouwers M; van Hillegersberg R; Porte RJ; Rijken AM; Strobbe LJ; de Wilt JH;
Eur J Surg Oncol; 2012 Oct; 38(10):910-7. PubMed ID: 22682709
[TBL] [Abstract][Full Text] [Related]
3. Comparison of hepatic recurrences after resection or intraoperative radiofrequency ablation indicated by size and topographical characteristics of the metastases.
Leblanc F; Fonck M; Brunet R; Becouarn Y; Mathoulin-Pélissier S; Evrard S
Eur J Surg Oncol; 2008 Feb; 34(2):185-90. PubMed ID: 17998155
[TBL] [Abstract][Full Text] [Related]
4. [CT-guided radiofrequency ablation of liver metastases from colorectal cancer].
Mahnken AH; Bruners P; Tacke JA; Günther RW
Dtsch Med Wochenschr; 2009 May; 134(19):976-80. PubMed ID: 19401962
[TBL] [Abstract][Full Text] [Related]
5. [Radiofrequency ablation in primary and secondary liver tumors].
Carditello A; Scisca C; David A; Stilo F; Basile M
Chir Ital; 2002; 54(1):83-6. PubMed ID: 11942016
[TBL] [Abstract][Full Text] [Related]
6. Factors in successful radiofrequency ablation therapy for malignant liver tumors.
Sakakima Y; Inoue S; Takeda S; Kaneko T; Nakao A
Hepatogastroenterology; 2004; 51(60):1761-5. PubMed ID: 15532821
[TBL] [Abstract][Full Text] [Related]
7. Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation.
Gleisner AL; Choti MA; Assumpcao L; Nathan H; Schulick RD; Pawlik TM
Arch Surg; 2008 Dec; 143(12):1204-12. PubMed ID: 19075173
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update.
Mulier S; Ruers T; Jamart J; Michel L; Marchal G; Ni Y
Dig Surg; 2008; 25(6):445-60. PubMed ID: 19212117
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery.
Park IJ; Kim HC; Yu CS; Kim PN; Won HJ; Kim JC
Ann Surg Oncol; 2008 Jan; 15(1):227-32. PubMed ID: 17882491
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease.
Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH
Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366
[TBL] [Abstract][Full Text] [Related]
11. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases.
Oshowo A; Gillams A; Harrison E; Lees WR; Taylor I
Br J Surg; 2003 Oct; 90(10):1240-3. PubMed ID: 14515293
[TBL] [Abstract][Full Text] [Related]
12. Surgical management of hepatic breast cancer metastases.
Podnos YD; Wagman LD
Oncology (Williston Park); 2005 Nov; 19(12):1583-7; discussion 1587-8, 1590 passim. PubMed ID: 16396152
[TBL] [Abstract][Full Text] [Related]
13. Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver.
Tanaka K; Shimada H; Nagano Y; Endo I; Sekido H; Togo S
Surgery; 2006 Feb; 139(2):263-73. PubMed ID: 16455336
[TBL] [Abstract][Full Text] [Related]
14. Clinical short-term results of radiofrequency ablation in patients with liver metastases from colorectal cancer.
Basdanis G; Michalopoulos A; Papadopoulos V; Tzeveleki I; Efthimiadis Ch; Kosmidis Ch; Mekras D; Harlaftis N
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s187-9. PubMed ID: 15655617
[TBL] [Abstract][Full Text] [Related]
15. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma.
Kim HR; Cheon SH; Lee KH; Ahn JR; Jeung HC; Lee SS; Chung HC; Noh SH; Rha SY
Int J Hyperthermia; 2010; 26(4):305-15. PubMed ID: 20210605
[TBL] [Abstract][Full Text] [Related]
17. [Radiofrequency ablation of colorectal metastases to the liver: results since the first application in the Netherlands].
Blussé van Oud-Alblas M; Fioole B; Jansen MC; van Duijnhoven FH; van Hillegersberg R; Rijken AM; van Coevorden F; Borel Rinkes IH
Ned Tijdschr Geneeskd; 2008 Apr; 152(15):880-6. PubMed ID: 18512529
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation in the treatment of breast cancer liver metastases.
Illing R; Gillams A
Clin Oncol (R Coll Radiol); 2010 Nov; 22(9):781-4. PubMed ID: 20829004
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of hepatic resection and radiofrequency ablation in patients with solitary colorectal liver metastasis.
Lee WS; Yun SH; Chun HK; Lee WY; Kim SJ; Choi SH; Heo JS; Joh JW; Choi D; Kim SH; Rhim H; Lim HK
J Clin Gastroenterol; 2008 Sep; 42(8):945-9. PubMed ID: 18438208
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous radiofrequency ablation of ovarian cancer metastasis to the liver: indications, outcomes, and role in patient management.
Gervais DA; Arellano RS; Mueller PR
AJR Am J Roentgenol; 2006 Sep; 187(3):746-50. PubMed ID: 16928940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
